Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

A Guinea Pig Maximization Test according to OECD Guideline 406 under GLP compliance was performed with the test item. Skin reactions after challenge were found in the test animals as well as in the control animals. They consisted of slight erythema of similar intensity. Therefore 1,2 -dichchloro-4-nitrobenzene was evaluated to be a non-sensitizing substance.  Under the conditions of this Guinea Pig Maximization test 1,2-dichloro-4-nitrobenzene was evaluated as non-sensitizer (Bayer AG 1991).

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study, GLP
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
12 May 1981
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The study was performed before the LLNA became the standard method
Species:
guinea pig
Strain:
other: BOR:DHPW
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Age at study initiation: 4-8 weeks
- Weight at study initiation: 342 g (mean weight, 290 - 403 g)
- Housing: 5/cage
- Diet ad libitum
- Water ad libitum
- Acclimation period: 7 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 50
- Air changes (per hr): 10/hour
- Photoperiod (hrs dark / hrs light): 12/12
Route:
intradermal
Vehicle:
other: PEG 400
Concentration / amount:
5 %
Day(s)/duration:
Day 1
Route:
epicutaneous, occlusive
Vehicle:
other: PEG 400
Concentration / amount:
50 %
Day(s)/duration:
Day 8: for 48 hours
Adequacy of induction:
non-irritant substance, but skin pre-treated with 10% SDS
No.:
#1
Route:
epicutaneous, semiocclusive
Vehicle:
other: PEG 400
Concentration / amount:
50 %
Day(s)/duration:
Week 3 for 24 h
No.:
#2
Route:
epicutaneous, semiocclusive
Vehicle:
other: PEG 400
Concentration / amount:
25 % and 12 %
Day(s)/duration:
Week 4 for 24 h
No. of animals per dose:
20 animals in the test group and 10 in each of the two control groups
Details on study design:
according to OECD TG 406
Challenge controls:
yes
Positive control substance(s):
no
Positive control results:
none
Group:
positive control
Remarks on result:
not measured/tested
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
first provocation: 50 %
No. with + reactions:
12
Total no. in group:
20
Clinical observations:
reduced body weight gain
Reading:
2nd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
first provocation 50 %
No. with + reactions:
7
Total no. in group:
20
Clinical observations:
reduced body weight gain
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
first provocation 50 %
No. with + reactions:
7
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
72
Group:
negative control
Dose level:
first provocation : 50 %
No. with + reactions:
3
Total no. in group:
10
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
second provocation: 25 %
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
reduced weight gain
Reading:
2nd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
second provocation: 25 %
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
reduced weight gain
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
second provocation: 25 %
No. with + reactions:
1
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
72
Group:
negative control
Dose level:
second provocation: 25 %
No. with + reactions:
0
Total no. in group:
10
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
second provocation: 12 %
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
reduced weight gain
Reading:
2nd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
second provocation : 12 %
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
reduced weight gain
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
second provocation: 12 %
No. with + reactions:
0
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
72
Group:
negative control
Dose level:
second provocation: 12 %
No. with + reactions:
0
Total no. in group:
10
Reading:
other: overall
Hours after challenge:
72
Group:
negative control
Dose level:
0 (no induction, no challenge)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no findings

no mortality, reduced body weight gain in treated groups compared to the control group.


The skin reactions in the test animals as well as in the control animals consist of slight erythema of similar intensity.


Therefore 1,2 -dichchloronitrobenzene was evaluated to be a non-sensitizing substance.


 

Interpretation of results:
GHS criteria not met
Conclusions:
Under the conditions of this Guinea Pig Maximization test 1,2 -dichloro-4 -nitrobenzene was evaluated as non-sensitizer (Bayer AG 1991).
Executive summary:

A Guinea Pig Maximization Test according to OECD Guideline 406 under GLP compliance was performed with the test item. Skin reactions after challenge were found in the test animals as well as in the control animals. They consisted of slight erythema of similar intensity. Therefore 1,2 -dichchloro-4-nitrobenzene was evaluated to be a non-sensitizing substance.  Under the conditions of this Guinea Pig Maximization test 1,2-dichloro-4-nitrobenzene was evaluated as non-sensitizer (Bayer AG 1991).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Under the conditions of this Guinea Pig Maximization test 1,2 -dichloro-4 -nitrobenzene was evaluated as non-sensitizer (Bayer AG) 1991). Therefore the substnce is not classified in accordance with Regulation (EC) No 1272/2008.